CD8A and tuberculosis: Previous studies have demonstrated the importance of induction of the unconventionally MHC-E restricted CD8+ T cell responses by 68-1 RhCMV vector vaccines for efficacy against SIV (4–6, 17), whereas protection mediated by RhCMV/TB does not specifically require MHC-E restriction (7).